Two Sigma Investments, LP Cyclerion Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.47 - $1.29 $19,928 - $54,696	-42,400 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.96 - $1.78 $91,379 - $169,432	-95,187 Reduced 69.18%	42,400 $47,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.99 $394,694 - $756,496	-253,009 Reduced 64.78%	137,587 $237,000
Q3 2021 Nov 15, 2021	BUY	$2.73 - $4.13 $646,726 - $978,380	236,896 Added 154.13%	390,596 $1.2 Million
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.29 $6,999 - $13,775	-3,211 Reduced 2.05%	153,700 $599,000
Q1 2021 May 17, 2021	BUY	$2.69 - $5.12 $132,170 - $251,566	49,134 Added 45.59%	156,911 $438,000
Q4 2020 Feb 16, 2021	BUY	$2.25 - $7.12 $242,498 - $767,372	107,777 New	107,777 $330,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.84 $241,355 - $572,974	-98,112 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.8 - $13.43 $176,601 - $1.32 Million	98,112 New	98,112 $267,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $153M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.